drugset / Trial / NCT01216163

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

NCT01216163

Phase 3 Completed 218 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the analgesic efficacy of a single-dose of a novel ibuprofen formulation to placebo and acetaminophen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.

Timeline

Start
2010-10
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg
Subject Ibuprofen Small molecule 512 mg

Indications

No indication recorded.